title: Genetic basis of nephrotic syndrome--review.
abstract: Nephrotic syndrome (NS) is one of the most frequent syndromes characterized namely by heavy proteinuria. Majority of NS occurs as a sporadic form, the incidence of familial cases is from 3 to 5%. Seven genes have been recognized till present, which mutations are responsible for severe forms of NS: NPHS1, NPHS2, ACTN4, CD2AP and WT1, TRPC6, LAMB2. Proteins encoded by these genes (nephrin, podocin, alpha-actinin-4, an adapter protein anchoring CD2 and others) influence the function of the podocytes. In cases of mutation in NPHS1 gene, causing congenital nephrotic syndrome of the Finnish type (CNF), resistance to steroid therapy occurs regularly and recurrence of proteinuria after renal transplantation is about 20-25%. Mutations in NPHS2 gene lead to autosomal recessive steroid resistant nephrotic syndrome (histologically focal segmental glomerulosclerosis). It was concluded that patients with steroid resistant nephrotic syndrome (SRNS) with homozygous or compound heterozygous mutations in NPHS2 have reduced risk for recurrence of focal segmental glomerulosclerosis (FSGS) in renal transplant (only 8% in comparison with 35% in patients without mutation in NPHS2). A functional polymorphism of NPHS2 gene--R229Q was associated with a late-onset nephrotic syndrome and also with an increased risk of microalbuminuria in the general population. The R229Q variant encodes a protein with lower affinity for binding nephrin. This polymorphism appears to enhance susceptibility to FSGS in association with a second mutant NPHS2 allele. There are also 3 genetic loci connected with autosomal dominant forms of FSGS: ACTN4, TRPC6 and CD2AP (found only in the mice models). These forms of FSGS differ from the recessive form by later-onset and more slowly progressive course of the disease; these mutations seem to be responsible for only a fraction of the autosomal dominant pattern of FSGS.
authors.affiliation: Department of Nephrology of the First Faculty of Medicine, Charles University in Prague, Czech Republic. diebo@email.cz
authors.forename: H
authors.initials: H
authors.lastname: Obeidová
authors.forename: M
authors.initials: M
authors.lastname: Merta
authors.forename: J
authors.initials: J
authors.lastname: Reiterová
authors.forename: D
authors.initials: D
authors.lastname: Maixnerová
authors.forename: J
authors.initials: J
authors.lastname: Stekrová
authors.forename: R
authors.initials: R
authors.lastname: Rysavá
authors.forename: V
authors.initials: V
authors.lastname: Tesar
mesh_terms: D005923:Glomerulosclerosis, Focal Segmental / Q000235:genetics; D006801:Humans; D009154:Mutation; D009404:Nephrotic Syndrome / Q000151:congenital / Q000235:genetics* / Q000503:physiopathology; D011110:Polymorphism, Genetic